The integration of genomic medicine and personalized therapies in our healthcare systems : an analysis of the economic, legislative, and organizational current state and feasibility at a national scale (or across multiple countries, such as France and the United States), and an assessment of the potential for large-scale industrialization of these emerging technologies. / Neil Tazi

0 review

The integration of genomic medicine and personalized therapies in our healthcare systems : an analysis of the economic, legislative, and organizational current state and feasibility at a national scale (or across multiple countries, such as France and the United States), and an assessment of the potential for large-scale industrialization of these emerging technologies. / Neil Tazi

Study and report

Tazi, Neil

Published by ESCP Business School - 2025

Library: Paris Champerret Paris Montparnasse Berlin Madrid London Turin

Source : Syracuse

Item type

Study and report

Dissertation

MSM Biopharmaceutical Management

Language

English

Publication year: 2025

Subjects: HEALTH - INNOVATION - FRANCE - UNITED STATES OF AMERICA

This thesis examines the integration and accessibility of genomic medicine and PT within healthcare systems, with a particular focus on France and comparisons to the United States. It analyzes the scientific promises and economic, organizational, and regulatory challenges that shape large-scale adoption. Through an assessment of healthcare pathways, industrial and logistical constraints, pricing strategies, and regulatory frameworks, the study investigates whether genomic medicine can transition from highly specialized interventions to broader accessibility. Finally, it proposes strategic recommendations to reconcile the tension between personalization and industrialization, ensuring both clinical value and equitable access for patients.